Application Nr Approved Date Route Status External Links
ANDA204074 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Dermatitis Herpetiformis: (D.h.) Leprosy: All Forms Of Leprosy Except For Cases Of Proven Dapsone Resistance.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dapsone DAPSONE ZINC6310

Comments